{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T21:01:23Z","timestamp":1722718883128},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Physiol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>One of the hallmarks of Alzheimer's disease, and several other degenerative disorders such as Inclusion Body Myositis, is the abnormal accumulation of amyloid precursor protein (APP) and its proteolytic amyloid peptides. To better understand the pathological consequences of inappropriate APP expression on developing tissues, we generated transgenic flies that express wild-type human APP in the skeletal muscles, and then performed anatomical, electrophysiological, and behavioral analysis of the adults.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We observed that neither muscle development nor animal longevity was compromised in these transgenic animals. However, human APP expressing adults developed age-dependent defects in both climbing and flying. We could advance or retard the onset of symptoms by rearing animals in vials with different surface properties, suggesting that human APP expression-mediated behavioral defects are influenced by muscle activity. Muscles from transgenic animals did not display protein aggregates or structural abnormalities at the light or transmission electron microscopic levels. In agreement with genetic studies performed with developing mammalian myoblasts, we observed that co-expression of the ubiquitin E3 ligase Parkin could ameliorate human APP-induced defects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These data suggest that: 1) ectopic expression of human APP in fruit flies leads to age- and activity-dependent behavioral defects without overt changes to muscle development or structure; 2) environmental influences can greatly alter the phenotypic consequences of human APP toxicity; and 3) genetic modifiers of APP-induced pathology can be identified and analyzed in this model.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6793-11-7","type":"journal-article","created":{"date-parts":[[2011,4,27]],"date-time":"2011-04-27T06:23:37Z","timestamp":1303885417000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Expression of human amyloid precursor protein in the skeletal muscles of Drosophila results in age- and activity-dependent muscle weakness"],"prefix":"10.1186","volume":"11","author":[{"given":"Chul","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sapeckshita","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja A","family":"Godenschwege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saranya","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig T","family":"Woodard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence M","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,25]]},"reference":[{"key":"176_CR1","doi-asserted-by":"publisher","first-page":"29615","DOI":"10.1074\/jbc.R800019200","volume":"283","author":"G Thinakaran","year":"2008","unstructured":"Thinakaran G, Koo EH: Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008, 283: 29615-29619. 10.1074\/jbc.R800019200.","journal-title":"J Biol Chem"},{"key":"176_CR2","doi-asserted-by":"publisher","first-page":"12683","DOI":"10.1073\/pnas.95.21.12683","volume":"95","author":"H Meziane","year":"1998","unstructured":"Meziane H, Dodart JC, Mathis C, Little S, Clemens J, Paul SM, Ungerer A: Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci USA. 1998, 95: 12683-12688. 10.1073\/pnas.95.21.12683.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1515\/REVNEURO.2000.11.2-3.75","volume":"11","author":"JC Dodart","year":"2000","unstructured":"Dodart JC, Mathis C, Ungerer A: The beta-amyloid precursor protein and its derivatives: from biology to learning and memory processes. Rev Neurosci. 2000, 11: 75-93.","journal-title":"Rev Neurosci"},{"key":"176_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ: Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 1992, 360: 672-674. 10.1038\/360672a0.","journal-title":"Nature"},{"key":"176_CR5","first-page":"267","volume":"11","author":"M Folin","year":"2003","unstructured":"Folin M, Baiguera S, Conconi MT, Pati T, Grandi C, Parnigotto PP, Nussdorfer GG: The impact of risk factors of Alzheimer's disease in the Down syndrome. Int J Mol Med. 2003, 11: 267-270.","journal-title":"Int J Mol Med"},{"key":"176_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng0394-251","volume":"6","author":"KM Felsenstein","year":"1994","unstructured":"Felsenstein KM, Hunihan LW, Roberts SB: Altered cleavage and secretion of a recombinant beta-APP bearing the Swedish familial Alzheimer's disease mutation. Nat Genet. 1994, 6: 251-255. 10.1038\/ng0394-251.","journal-title":"Nat Genet"},{"key":"176_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe D: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007, 8: 101-112. 10.1038\/nrm2101.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"176_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y: Visualization of Ab42(43) and Ab40 in senile plaques with end-specific Ab monoclonals: Evidence that aninitially deposited species is Ab42(43). Neuron. 1994, 13: 45-53. 10.1016\/0896-6273(94)90458-8.","journal-title":"Neuron"},{"key":"176_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/exnr.1996.0048","volume":"138","author":"PS Puttfarcken","year":"1996","unstructured":"Puttfarcken PS, Manelli AM, Neilly J, Frail DE: Inhibition of age-induced beta-amyloid neurotoxicity in rat hippocampal cells. Exp Neurol. 1996, 138: 73-81. 10.1006\/exnr.1996.0048.","journal-title":"Exp Neurol"},{"key":"176_CR10","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1073\/pnas.94.4.1550","volume":"94","author":"K Johnson-Wood","year":"1997","unstructured":"Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, Lieberburg I, Schenk D, Seubert P, McConlogue L: Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA. 1997, 94: 1550-1555. 10.1073\/pnas.94.4.1550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/08830738030180030401","volume":"18","author":"V Askanas","year":"2003","unstructured":"Askanas V, Engel WK: Unfolding story of inclusion-body myositis and myopathies: role of misfolded proteins, amyloid-beta, cholesterol, and aging. J Child Neurol. 2003, 18: 185-190. 10.1177\/08830738030180030401.","journal-title":"J Child Neurol"},{"key":"176_CR12","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp.2009.173823","volume":"80","author":"AA Amato","year":"2009","unstructured":"Amato AA, Barohn RJ: Inclusion body myositis: old and new concepts. J Neurol Neurosurg Psychiatry. 2009, 80: 1186-1193. 10.1136\/jnnp.2009.173823.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"176_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","volume":"6","author":"MC Dalakas","year":"2010","unstructured":"Dalakas MC: Immunotherapy of myositis: issues, concerns and future prospects. Nat Rev Rheumatol. 2010, 6: 129-137. 10.1038\/nrrheum.2010.2.","journal-title":"Nat Rev Rheumatol"},{"key":"176_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00401-009-0511-6","volume":"117","author":"G Vattemi","year":"2009","unstructured":"Vattemi G, Nogalska A, King Engel W, D'Agostino C, Checler F, Askanas V: Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. Acta Neuropathol. 2009, 117: 569-574. 10.1007\/s00401-009-0511-6.","journal-title":"Acta Neuropathol"},{"key":"176_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0304-3940(95)11718-C","volume":"194","author":"FE Sherriff","year":"1995","unstructured":"Sherriff FE, Joachim CL, Squier MV, Esiri MM: Ubiquitinated inclusions in inclusion-body myositis patients are immunoreactive for cathepsin D but not beta-amyloid. Neurosci Lett. 1995, 194: 37-40. 10.1016\/0304-3940(95)11718-C.","journal-title":"Neurosci Lett"},{"key":"176_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mus.21230","volume":"39","author":"KC Parker","year":"2009","unstructured":"Parker KC, Kong SW, Walsh RJ, Bch , Salajegheh M, Moghadaszadeh B, Amato AA, Nazareno R, Lin YY, Krastins B, Sarracino DA, Beggs AH, Pinkus JL, Greenberg SA: Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis. Muscle Nerve. 2009, 39: 739-753. 10.1002\/mus.21230.","journal-title":"Muscle Nerve"},{"key":"176_CR17","doi-asserted-by":"publisher","first-page":"b2680","DOI":"10.1136\/bmj.b2680","volume":"339","author":"SA Greenberg","year":"2009","unstructured":"Greenberg SA: How citation distortions create unfounded authority: analysis of a citation network. BMJ. 2009, 339: b2680-10.1136\/bmj.b2680.","journal-title":"BMJ"},{"key":"176_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11910-009-0013-x","volume":"9","author":"SA Greenberg","year":"2009","unstructured":"Greenberg SA: Inclusion body myositis: review of recent literature. Curr Neurol Neurosci Rep. 2009, 9: 83-89. 10.1007\/s11910-009-0013-x.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"176_CR19","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1073\/pnas.93.3.1314","volume":"93","author":"V Askanas","year":"1996","unstructured":"Askanas V, McFerrin J, Baqu\u00e9 S, Alvarez RB, Sarkozi E, Engel WK: Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci USA. 1996, 93: 1314-1319. 10.1073\/pnas.93.3.1314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1006\/mcne.2001.0972","volume":"17","author":"HW Querfurth","year":"2001","unstructured":"Querfurth HW, Suhara T, Rosen KM, McPhie DL, Fujio Y, Tejada G, Neve RL, Adelman LS, Walsh K: Beta-amyloid peptide expression is sufficient for myotube death: implications for human inclusion body myopathy. Mol Cell Neurosci. 2001, 17: 793-810. 10.1006\/mcne.2001.0972.","journal-title":"Mol Cell Neurosci"},{"key":"176_CR21","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1096\/fj.06-5763fje","volume":"20","author":"CE Moussa","year":"2006","unstructured":"Moussa CE, Fu Q, Kumar P, Shtifman A, Lopez JR, Allen PD, LaFerla F, Weinberg D, Magrane J, Aprahamian T, Walsh K, Rosen KM, Querfurth HW: Transgenic expression of beta-APP in fast-twitch skeletal muscles leads to calcium dyshomeostasis and IBM-like pathology. FASEB J. 2006, 20: 2165-2167. 10.1096\/fj.06-5763fje.","journal-title":"FASEB J"},{"key":"176_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.neurobiolaging.2005.02.011","volume":"27","author":"MC Sugarman","year":"2006","unstructured":"Sugarman MC, Kitazawa M, Baker M, Caiozzo VJ, Querfurth HW, LaFerla FM: Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model. Neurobiol Aging. 2006, 27: 423-432. 10.1016\/j.neurobiolaging.2005.02.011.","journal-title":"Neurobiol Aging"},{"key":"176_CR23","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1073\/pnas.082545599","volume":"99","author":"MC Sugarman","year":"2002","unstructured":"Sugarman MC, Yamasaki TR, Oddo S, Echegoyen JC, Murphy MP, Golde TE, Jannatipour M, Leissring MA, LaFerla FM: Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle. Proc Natl Acad Sci USA. 2002, 99: 6334-6339. 10.1073\/pnas.082545599.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0896-6273(92)90024-8","volume":"9","author":"L Luo","year":"1992","unstructured":"Luo L, Tully T, White K: Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Neuron. 1992, 9: 595-605. 10.1016\/0896-6273(92)90024-8.","journal-title":"Neuron"},{"key":"176_CR25","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1073\/pnas.91.12.5662","volume":"91","author":"B Lilly","year":"1994","unstructured":"Lilly B, Galewsky S, Firulli AB, Schulz RA, Olson EN: D-MEF2: a MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis. Proc Natl Acad Sci USA. 1994, 91: 5662-5666. 10.1073\/pnas.91.12.5662.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR26","doi-asserted-by":"publisher","first-page":"58555865","DOI":"10.1523\/JNEUROSCI.2688-09.2010","volume":"30","author":"FJ Blanchard","year":"2010","unstructured":"Blanchard FJ, Collins B, Cyran SA, Hancock DH, Taylor MV, Blau J: The transcription factor Mef2 is required for normal circadian behavior in Drosophila. J Neurosci. 2010, 30: 58555865-","journal-title":"J Neurosci"},{"key":"176_CR27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998, 392: 605-608. 10.1038\/33416.","journal-title":"Nature"},{"key":"176_CR28","doi-asserted-by":"publisher","first-page":"12809","DOI":"10.1074\/jbc.M512649200","volume":"281","author":"KM Rosen","year":"2006","unstructured":"Rosen KM, Veereshwarayya V, Moussa CE, Fu Q, Goldberg MS, Schlossmacher MG, Shen J, Querfurth HW: Parkin protects against mitochondrial toxins and beta-amyloid accumulation in skeletal muscle cells. J Biol Chem. 2006, 281: 12809-12816. 10.1074\/jbc.M512649200.","journal-title":"J Biol Chem"},{"key":"176_CR29","doi-asserted-by":"publisher","first-page":"6623","DOI":"10.1073\/pnas.0400895101","volume":"101","author":"K Iijima","year":"2004","unstructured":"Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y: Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natl Acad Sci USA. 2004, 101: 6623-6628. 10.1073\/pnas.0400895101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ana.410340408","volume":"34","author":"V Askanas","year":"1993","unstructured":"Askanas V, Alvarez RB, Engel WK: beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann Neurol. 1993, 34: 551-60. 10.1002\/ana.410340408.","journal-title":"Ann Neurol"},{"key":"176_CR31","doi-asserted-by":"publisher","first-page":"e6033","DOI":"10.1371\/journal.pone.0006033","volume":"24","author":"S Turdi","year":"2009","unstructured":"Turdi S, Guo R, Huff AF, Wolf EM, Culver B, Ren J: Cardiomyocyte contractile dysfunction in the APPswe\/PS1dE9 mouse model of Alzheimer's disease. PLoS One. 2009, 24: e6033-","journal-title":"PLoS One"},{"key":"176_CR32","doi-asserted-by":"publisher","first-page":"9368","DOI":"10.1073\/pnas.92.20.9368","volume":"92","author":"CD Link","year":"1995","unstructured":"Link CD: Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci USA. 1995, 92: 9368-9372. 10.1073\/pnas.92.20.9368.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0197-4580(02)00225-7","volume":"24","author":"J Drake","year":"2003","unstructured":"Drake J, Link CD, Butterfield DA: Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol Aging. 2003, 24: 415-420. 10.1016\/S0197-4580(02)00225-7.","journal-title":"Neurobiol Aging"},{"key":"176_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1326-4-2","volume":"4","author":"AN Minniti","year":"2009","unstructured":"Minniti AN, Rebolledo DL, Grez PM, Fadic R, Aldunate R, Volitakis I, Cherny RA, Opazo C, Masters C, Bush AI, Inestrosa NC: Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification. Mol Neurodegener. 2009, 4: 2-10.1186\/1750-1326-4-2.","journal-title":"Mol Neurodegener"},{"key":"176_CR35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC: Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004, 36: 585-595. 10.1038\/ng1362.","journal-title":"Nat Genet"},{"key":"176_CR36","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.neurobiolaging.2008.11.003","volume":"31","author":"A Shtifman","year":"2010","unstructured":"Shtifman A, Ward CW, Laver DR, Bannister ML, Lopez JR, Kitazawa M, Laferla FM, Ikemoto N, Querfurth HW: Amyloid-beta protein impairs Ca(2+) release and contractility in skeletal muscle. Neurobiol Aging. 2010, 31: 2080-2090. 10.1016\/j.neurobiolaging.2008.11.003.","journal-title":"Neurobiol Aging"},{"key":"176_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ana.21325","volume":"64","author":"M Kitazawa","year":"2008","unstructured":"Kitazawa M, Trinh DN, LaFerla FM: Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta. Ann Neurol. 2008, 64: 15-24. 10.1002\/ana.21325.","journal-title":"Ann Neurol"},{"key":"176_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4161\/auto.4245","volume":"3","author":"JD L\u00fcnemann","year":"2007","unstructured":"L\u00fcnemann JD, Schmidt J, Dalakas MC, M\u00fcnz C: Macroautophagy as a pathomechanism in sporadic inclusion body myositis. Autophagy. 2007, 3: 384-386.","journal-title":"Autophagy"},{"key":"176_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00401-005-1035-3","volume":"110","author":"S W\u00f3jcik","year":"2005","unstructured":"W\u00f3jcik S, Engel WK, McFerrin J, Askanas V: Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers. Acta Neuropathol. 2005, 110: 173-177. 10.1007\/s00401-005-1035-3.","journal-title":"Acta Neuropathol"},{"key":"176_CR40","first-page":"13","volume":"25","author":"O Paciello","year":"2006","unstructured":"Paciello O, W\u00f3jcik S, Engel WK, McFerrin J, Askanas V: Parkin and its association with alpha-synuclein and AbetaPP in inclusion-body myositis and AbetaPP-overexpressing cultured human muscle fibers. Acta Myol. 2006, 25: 13-22.","journal-title":"Acta Myol"},{"key":"176_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jnr.22178","volume":"88","author":"KM Rosen","year":"2010","unstructured":"Rosen KM, Moussa CE, Lee HK, Kumar P, Kitada T, Qin G, Fu Q, Querfurth HW: Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function. J Neurosci Res. 2010, 88: 167-178. 10.1002\/jnr.22178.","journal-title":"J Neurosci Res"},{"key":"176_CR42","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1073\/pnas.0737556100","volume":"100","author":"JC Greene","year":"2003","unstructured":"Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ: Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA. 2003, 100: 4078-4083. 10.1073\/pnas.0737556100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR43","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbrc.2008.11.086","volume":"378","author":"J Park","year":"2009","unstructured":"Park J, Lee G, Chung J: The PINK1-Parkin pathway is involved in the regulation of mitochondrial remodeling process. Biochem Biophys Res Commun. 2009, 378: 518-523. 10.1016\/j.bbrc.2008.11.086.","journal-title":"Biochem Biophys Res Commun"},{"key":"176_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/16501970306110","volume":"35","author":"S Arnardottir","year":"2003","unstructured":"Arnardottir S, Alexanderson H, Lundberg IE, Borg K: Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J Rehabil Med. 2003, 35: 31-35. 10.1080\/16501970306110.","journal-title":"J Rehabil Med"},{"key":"176_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/01.bor.0000152665.41493.49","volume":"17","author":"H Alexanderson","year":"2005","unstructured":"Alexanderson H, Lundberg IE: The role of exercise in the rehabilitation of idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2005, 17: 164-171. 10.1097\/01.bor.0000152665.41493.49.","journal-title":"Curr Opin Rheumatol"},{"key":"176_CR46","doi-asserted-by":"publisher","first-page":"13354","DOI":"10.1073\/pnas.240347797","volume":"97","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Gao J, Chung KK, Huang H, Dawson VL, Dawson TM: Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA. 2000, 97: 13354-13359. 10.1073\/pnas.240347797.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR47","volume-title":"Cold Spring Harb Protoc","author":"MJ Allen","year":"2010","unstructured":"Allen MJ, Godenschwege TA: Electrophysiological Recordings from the Giant Fiber System. Cold Spring Harb Protoc. 2010, 8: (2010) pdb.prot5453"},{"key":"176_CR48","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1038\/sj.emboj.7601117","volume":"25","author":"A Chartier","year":"2006","unstructured":"Chartier A, Benoit B, Simonelig M: A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1. EMBO J. 2006, 25: 2253-2262. 10.1038\/sj.emboj.7601117.","journal-title":"EMBO J"},{"key":"176_CR49","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/hmg\/ddm254","volume":"16","author":"MJ Allikian","year":"2007","unstructured":"Allikian MJ, Bhabha G, Dospoy P, Heydemann A, Ryder P, Earley JU, Wolf MJ, Rockman HA, McNally EM: Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants. Hum Mol Genet. 2007, 16: 2933-2943. 10.1093\/hmg\/ddm254.","journal-title":"Hum Mol Genet"}],"container-title":["BMC Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6793-11-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:59:27Z","timestamp":1630504767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcphysiol.biomedcentral.com\/articles\/10.1186\/1472-6793-11-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,25]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["176"],"URL":"https:\/\/doi.org\/10.1186\/1472-6793-11-7","relation":{},"ISSN":["1472-6793"],"issn-type":[{"value":"1472-6793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,25]]},"assertion":[{"value":"30 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}